3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
8
Terminated
2
Withdrawn
1
Unknown
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
17
Burkitt Lymphoma
11
Myelodysplastic Syndromes
6
Leukemia, Myeloid, Acute
6
Leukemia, Biphenotypic, Acute
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, Mantle-Cell
4
Leukemia, Myeloid, Accelerated Phase
4
Blast Crisis
4
Lymphoma
3
Leukemia
3
Rhabdoid Tumor
2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Leukemia, Myelomonocytic, Juvenile
2
Leukemia, Myeloid, Chronic-Phase
2
Graft vs Host Disease
2
Down Syndrome
2
Central Nervous System Neoplasms
2
Waldenstrom Macroglobulinemia
1
Urinary Bladder Neoplasms
1
Thrombocythemia, Essential
1
Solid Tumors
1
Sezary Syndrome
1
Sarcoma
1
Recurrence
1
Primary Myelofibrosis
1
Interventions
Radiotherapy
11
pembrolizumab
10
Nivolumab
10
Doxorubicin
10
Magnetic Resonance Spectroscopy
9
Specimen Handling
8
Ipilimumab
7
Cyclophosphamide
7
Biopsy
7
X-Rays
6
Radiation
5
Phantoms, Imaging
5
Ifosfamide
5
talimogene laherparepvec
4
cabozantinib
4
Nuclear Medicine Department, Hospital
4
Irinotecan
4
tazemetostat
3
selpercatinib
3
pazopanib
3
liposomal doxorubicin
3
Temozolomide
3
Etoposide
3
ulixertinib
2
tislelizumab
2
tipifarnib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
fludarabine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Sarcoma
×
Methotrexate
×
Clear all
NCT00470223
2025-06-08
OS2006
UNICANCER
Phase 3
Active not recruiting
318 enrolled